Skip to content

Effect of Single-Dose Intravenous Dexamethasone on Pain Control and Functional Recovery After Volar Locking Plate Fixation of Distal Radius Fractures: A Prospective, Double-Blind, Randomized Controlled Trial

Effect of Single-Dose Intravenous Dexamethasone on Pain Control and Functional Recovery After Volar Locking Plate Fixation of Distal Radius Fractures: A Prospective, Double-Blind, Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260511001
Enrollment
104
Registered
2026-05-11
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Distal radius fractures Postoperative pain Distal radius fractures Dexamethasone Postoperative pain Volar locking plate Functional recovery Bone plates

Interventions

Participants will receive a single intravenous dose of 8 mg dexamethasone during the induction of anesthesia before the surgical incision.,Participants will receive a single intravenous dose of steril
Experimental Drug,Placebo Comparator Other
Intravenous Dexamethasone 8 mg,Placebo (Normal Saline)

Sponsors

Kamphaeng Phet Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Male or female patients aged 18 years or older, 2. Diagnosed with distal radius fracture indicated for open reduction and internal fixation (ORIF) with a volar locking plate, 3. American Society of Anesthesiologists (ASA) physical status I, II, or III, 4.Able to communicate, understand the study information, and provide voluntary written informed consent.

Exclusion criteria

Exclusion criteria: 1. History of allergy to dexamethasone or any component of the study drug, 2. Diagnosis of Diabetes Mellitus (Type 1 or 2) or significant preoperative hyperglycemia, 3. History of continuous corticosteroid use or received steroids within 30 days prior to surgery, 4.Active systemic infection or skin infection at the surgical site, 5.Open fracture or associated severe vascular or nerve injury, 6. Immunocompromised state or currently receiving immunosuppressive drugs, 7.Pregnant, planning pregnancy, or breastfeeding, 8.History of chronic alcoholism or substance abuse, 9. Unable to cooperate with post-operative assessment (e.g., dementia, cognitive impairment, or uncontrolled psychiatric disorders).

Design outcomes

Primary

MeasureTime frame
Total opioid consumption Within the first 48 hours post-operation Cumulative dose of all opioids converted to oral

Secondary

MeasureTime frame
Postoperative pain score At 6, 12, 24, and 48 hours post-operation Numerical Rating Scale (NRS) ranging from 0 (no pain) to 10 (worst pain imaginable),Finger stiffness At 6, 12, and 24 weeks post-operation Tip-to-palm distance measured in centimeters,Wrist range of motion At 6, 12, and 24 weeks post-operation Degrees of flexion, extension, radial deviation, and ulnar deviation measured by goniometer

Countries

Thailand

Contacts

Public ContactIsarapong Duangmee

Kamphaeng Phet Hospital

isarapong.orthokpp@gmail.com0639469964

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026